Daily non-political popular news in brief.
Older medication may be more cost-effective for some patients with schizophrenia
12-01-2006 · EurekAlert!A new study analyzing the economic implications of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) concludes that the older (first generation) antipsychotic medication perphenazine was less expensive and no less effective than the newer (second generation) medications used in the trial during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia.
Read more »
Keywords: older, medication, cost-effective, patients, schizophrenia, cost, effective, patient
« Previous | Next »
Similar news on "Older medication may be more cost-effective for some patients with schizophrenia":
- New details in schizophrenia treatment trial emerge
03-01-2007 · EurekAlert!
Two new studies from the CATIE trial provide more insights into comparing treatment options, and to what extent antipsychotic medications help people with schizophrenia learn social, interpersonal and psychosocial skills. Quetiapine, and to some extent olanzapine, may be more effective than risperidone among patients who were originally taking, but had to discontinue, perphenazine -- an older, first generation antipsychotic medication. Patients taking antipsychotic medications, regardless of type, experience modest improvements in social, interpersonal and psychosocial skills.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
- Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
12-20-2007 · EurekAlert!
The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
Similar news · Read more »
- Bitter Pill: Costs surge for new schizophrenia drugs
12-09-2006 · Science News Online
Medications widely prescribed to treat schizophrenia cost hundreds of dollars more each month than does a less popular, older medication that has similar success at alleviating symptoms of the disorder.
Similar news · Read more »
- Effective new treatment for schizophrenia
12-13-2007 · EurekAlert!
Schizophrenia is one of the most debilitating of the major psychiatric disorders, and is also one of the most difficult to treat. Although numerous antipsychotic treatments are available, they can cause significant side effects and many patients experience only a partial relief of their symptoms and up to 30 percent no relief at all.
Similar news · Read more »
- Mayo Clinic real-time 3-D ultrasound speeds patient recovery
07-13-2007 · EurekAlert!
Mayo Clinic physicians have adapted real-time 3-D ultrasound imaging devices -- including one designed to look at an infant's heart -- so that they can watch as they use a needle filled with anesthetic to numb individual nerves located inches under the skin. In this way, they can quickly block nerve function in selected areas of the body prior to surgery, an advance that may spare patients from use of general anesthesia, and sends them home faster and with less need for pain medication.
Similar news · Read more »
- Clinical trials for diabetes drugs should measure outcomes important to patients
09-27-2007 · EurekAlert!
Most clinical trials for new diabetes drugs do not consider the impact medication will have on a patient's quality of life or other outcomes that are important to patients, such as the risk of developing complications associated with diabetes, according to a Mayo Clinic commentary in the current issue of the Lancet.
Similar news · Read more »
- Medication effective in treating depression in patients with coronary artery disease
01-23-2007 · EurekAlert!
Patients with symptoms of depression who have coronary artery disease showed improvement of their symptoms with use of the drug citalopram, but adding interpersonal psychotherapy did not appear to be of benefit, according to a study in the January 24/31 issue of JAMA.
Similar news · Read more »
- New anti-psychotic drugs no better than older, cheaper ones
12-04-2006 · EurekAlert!
A study led by the University of Manchester's Division of Psychiatry has found that schizophrenia patients respond just as well -- and perhaps even better -- to older psychiatric drugs as newer, costlier alternatives.
Similar news · Read more »
- Preschoolers with ADHD improve with low doses of medication
10-16-2006 · EurekAlert!
The first long-term, large-scale study designed to determine the safety and effectiveness of treating preschoolers who have attention deficit/hyperactivity disorder with methylphenidate has found that overall, low doses of this medication are effective and safe. However, the study found that children this age are more sensitive than older children to the medication's side effects and therefore should be closely monitored.
Similar news · Read more »
